U. Bode

8.1k total citations · 1 hit paper
140 papers, 5.0k citations indexed

About

U. Bode is a scholar working on Genetics, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, U. Bode has authored 140 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Genetics, 35 papers in Oncology and 31 papers in Pulmonary and Respiratory Medicine. Recurrent topics in U. Bode's work include Glioma Diagnosis and Treatment (31 papers), Neuroblastoma Research and Treatments (19 papers) and Neutropenia and Cancer Infections (18 papers). U. Bode is often cited by papers focused on Glioma Diagnosis and Treatment (31 papers), Neuroblastoma Research and Treatments (19 papers) and Neutropenia and Cancer Infections (18 papers). U. Bode collaborates with scholars based in Germany, United States and Austria. U. Bode's co-authors include Gudrun Fleischhack, Arne Simon, Carola Hasan, Ulrich Jaehde, Norbert Graf, Stefan Rutkowski, Sandra Vezmar, Achim Becker, Torsten Pietsch and Monika Warmuth‐Metz and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

U. Bode

134 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treatment of Early Childhood Medulloblastoma by Postoperative Chemotherapy Alone

2005 505 citations Stefan Rutkowski, U. Bode et al. profile →

Peers

Countries citing papers authored by U. Bode

Since Specialization

Citations

This map shows the geographic impact of U. Bode's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U. Bode with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U. Bode more than expected).

Fields of papers citing papers by U. Bode

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by U. Bode. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U. Bode. The network helps show where U. Bode may publish in the future.

Co-authorship network of co-authors of U. Bode

This figure shows the co-authorship network connecting the top 25 collaborators of U. Bode. A scholar is included among the top collaborators of U. Bode based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with U. Bode. U. Bode is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Treatment of children under 4 years of age with medulloblastoma and ependymoma in the HIT2000/HIT-REZ 2005 trials: Neuropsychological outcome 5 years after treatment 2020 ·PLoS ONE ·Holger Ottensmeier, Paul G. Schlegel, Matthias Eyrich, Johannes Wolff, (unknown), Katja von Hoff, (unknown), René Schmidt, Andreas Faldum, Gudrun Fleischhack, André O. von Bueren, Carsten Friedrich, (unknown), Monika Warmuth‐Metz, Jürgen Krauß, Rolf D. Kortmann, U. Bode, Joachim Kühl, Stefan Rutkowski	13
2	Nimotuzumab and radiotherapy for treatment of newly diagnosed diffuse intrinsic pontine glioma (DIPG): a phase III clinical study 2019 ·Journal of Neuro-Oncology ·Gudrun Fleischhack, Maura Massimino, Monika Warmuth‐Metz, (unknown), G. Janßen, Norbert Graf, Stefan Rutkowski, Andreas Beilken, Irene Schmid, Veronica Biassoni, (unknown), Christof M. Kramm, Harald Reinhard, (unknown), Rolf‐Dieter Kortmann, Dirk Reuter, F. Bach, Normando Iznaga-Escobar, U. Bode	30
3	Multicentre prospective observational study on professional wound care using honey (Medihoney™) 2012 ·International Wound Journal ·Bahram Biglari, Arash Moghaddam, (unknown), Gisela Blaser, (unknown), Gisela Jansen, Alfred Längler, Norbert Graf, (unknown), (unknown), Anke Strölin, (unknown), (unknown), U. Bode, Tyler Swing, (unknown), Nicolas T. Schwarz, Arne Simon	40
4	Long‐term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphoma 2009 ·Annals of Neurology ·(unknown), Hendrik Pels, (unknown), Klaus Fließbach, Axel Glasmacher, Andreas Engert, Marcel Reiser, Volker Diehl, Marlies Vogt‐Schaden, Gerlinde Egerer, Gabriele Schackert, Heinz Reichmann, Frank Kroschinsky, U. Bode, Ulrich Herrlinger, Michael Linnebank, Martina Deckert, Rolf Fimmers, Ingo G.H. Schmidt‐Wolf, Uwe Schlegel	82
5	Marked elevation in homocysteine and homocysteine sulfinic acid in the cerebrospinal fluid of lymphoma patients receiving intensive treatment with methotrexate 2007 ·International Journal of Clinical Pharmacology and Therapeutics ·Albert J. Becker, Sandra Vezmar, Michael Linnebank, Hendrik Pels, U. Bode, Uwe Schlegel, Ulrich Jaehde	23
6	Mauer und Wand: Teil 1 2006 ·Mauerwerk ·U. Bode	0
7	Wound care with antibacterial honey (Medihoney) in pediatric hematology–oncology 2005 ·Supportive Care in Cancer ·Arne Simon, (unknown), (unknown), Gisela Blaser, U. Bode, Gudrun Fleischhack	76
8	Funktionale Steingewölbe während des 18. und frühen 19. Jahrhunderts 2004 ·Mauerwerk ·U. Bode	1
9	Oncological Management of Pediatric Cancer Patients Belonging to Jehovah’s Witnesses: A Two-Institutional Experience Report 2004 ·Oncology Research and Treatment ·Tobias Tenenbaum, Carola Hasan, Christof M. Kramm, G. Janßen, H.‐J. Laws, R. Wessalowski, U. Bode, U. Göbel	7
10	Diffuse hemangiolymphangiomatosis in an infant 2002 ·Medical and Pediatric Oncology ·G. Fleischhack, I. Theuerkauf, (unknown), (unknown), Carola Hasan, U. Bode	1
11	Carboxypeptidase-G 2 Rescue in Cancer Patients with Delayed Methotrexate Elimination after High-dose Methotrexate Therapy 2002 ·Leukemia & lymphoma ·Anke Krause, Martin R. Weihrauch, U. Bode, Gudrun Fleischhack, Thomas Elter, (unknown), Andreas Engert, Volker Diehl, Andreas Josting	30
12	Combined systemic and intraventricular chemotherapy in primary CNS lymphoma: Superior results in patients younger than 60 years 2001 ·Ghent University Academic Bibliography (Ghent University) ·Axel Glasmacher, Hendrik Pels, (unknown), Christoph Helmstaedter, P. Markus Deckert, Dirk Van Roost, (unknown), Frank Kroschinsky, (unknown), Kai Neben, An Thi Nhat Ho, Andreas Engert, Diehl, U. Bode, Thomas Klockgether, Uwe Schlegel, (unknown)	1
13	Piperacillin, beta-lactam inhibitor plus gentamicin as empirical therapy of a sequential regimen in febrile neutropenia of pediatric cancer patients 2001 ·Supportive Care in Cancer ·G. Fleischhack, (unknown), (unknown), W. Havers, G. Marklein, Carola Hasan, U. Bode	30
14	Immature Gastric Teratoma of the Lesser Curvature in a Male Infant 2001 ·Journal of Pediatric Gastroenterology and Nutrition ·Boris Utsch, Gudrun Fleischhack, G Knöpfle, Carola Hasan, U. Bode	1
15	Boswellic acids in the palliative therapy of children with progressive or relapsed brain tumors 2000 ·Klinische Pädiatrie ·G. Janßen, U. Bode, H. Breu, (unknown), V. Engelbrecht, U. Göbel	49
16	Complete resection before development of drug resistance is essential for survival from advanced hepatoblastoma—A report from the German Cooperative Pediatric Liver Tumor Study HB-89 1995 ·Journal of Pediatric Surgery ·Dietrich von Schweinitz, Hartmut Hecker, D. Harms, U. Bode, P. Weinel, D. Bürger, R. Erttmann, H. Mildenberger	106
17	Chronisch kranke Kinder und Jugendliche : eine interdisziplinäre Aufgabe 1990 ·Franz Petermann, U. Bode, (unknown)	2
18	Doxorubicin-Dauerinfusionen - Eine Pilotstudie bei jugendlichen Patienten 1988 ·Klinische Pädiatrie ·U. Bode, (unknown), W Köhler	1
19	Hochdosiertes ARA-C in Kombination mit Mitoxantron bei der Therapie der AML im Kindesalter 1987 ·Oncology Research and Treatment ·(unknown), U. Creutzig, G. Henze, H. Jürgens, U. Bode, G. Prindull, G. Schellong	5
20	Five Coping Styles in Families of Children with Cancer: A Retrospective Study in Thirty Families 1986 ·Pediatric Hematology and Oncology ·Franz Petermann, U. Bode	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact